Shukra Pharmaceuticals Ltd Q4FY22 PAT higher at Rs. 64.69 lakhs

Shukra Pharmaceuticals Ltd has reported Standalone financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 8.9730 crores during the period ended March 31, 2022 as compared to Rs. 3.0207 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 0.6469 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 0.0479 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 4.13 for the period ended March 31, 2022 as compared to Rs. 0.31 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 8.9730 crs	₹3.0207 crs	197.05%
Net Profit	₹0.6469 crs	₹0.0479 crs	1,250.52%
EPS	₹4.13	₹0.31	1,232.26%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 8.9730 crores during the period ended March 31, 2022 as compared to Rs.4.1094 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.6469 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-0.2319 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.4.13 for the period ended March 31, 2022 as compared to Rs.-1.48 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 8.9730 crs	₹4.1094 crs	118.35%
Net Profit	₹0.6469 crs	₹-0.2319 crs	378.96%
EPS	₹4.13	₹-1.48	379.05%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.20.5670 crores during the Financial Year ended March 31, 2022 as compared to Rs.11.5523 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.7507 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.0.0339 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.4.79 for the Financial Year ended March 31, 2022 as compared to Rs.0.22 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹20.5670 crs	₹11.5523 crs	78.03%
Net Profit	₹0.7507 crs	₹0.0339 crs	2,114.45%
EPS	₹4.79	₹0.22	2,077.27%

Shares of Shukra Pharmaceuticals Ltd was last trading in BSE at Rs. 58.00 as compared to the previous close of Rs. 57.70. The total number of shares traded during the day was 15 in over 3 trades.

The stock hit an intraday high of Rs. 58.00 and intraday low of 56.10. The net turnover during the day was Rs. 866.00.

Source : Equity Bulls

Keywords

ShukraPharmaceuticals Q4FY22 FY2022 ResultUpdate